K Pharma,Inc.
TSE Growth
¥806.00
+0.75%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Current assets comfortably cover current liabilities (current ratio 28.41).
!Watch-points
- Higher leverage: debt-to-equity of 1.32 is above 1.
- Thin interest cover: operating profit covers interest only about -929.1 times.
- Return on equity is on the lower side at -78.5%.
- Return on capital employed is on the lower side at -32.3%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-0.36
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥94億
Current Price¥ 806.00
High / Low¥ 949.00 / 604.00
Stock P/E-9.42
Book Value¥ 109.00
Dividend Yield0%
ROCE-32.28%
ROE-78.49%
Debt to Equity1.32
Current Ratio28.41
P/B Ratio9.227564
EPS¥ -85.59
ICR-929.06